Non‐Biological Complex Drugs/
News

FDA approves first follow-on version of glatiramer acetate

Non‐Biological Complex Drugs/News | Posted 05/11/2015

The US Food and Drug Administration (FDA) announced on 16 April 2015 the approval of the first follow-on version of glatiramer acetate injection used to treat patients with relapsing forms of multiple sclerosis (MS).